Latest News & Features
Asia-Pacific
Japan-based Takeda has revealed that it is considering plans to acquire biopharmaceutical company Shire. 3 April 2018
Americas
The US Court of Appeals for the Federal Circuit has ordered the Patent and Trial Appeal Board to halt its review of patents covering a dry eye medication while the court considers arguments that tribal immunity protects the patents from board proceedings. 29 March 2018
Biotechnology
The English Court of Appeal has reversed a finding that two of Regeneron’s European patents covering transgenic mice were insufficient. 29 March 2018
Americas
A US judge has overturned a jury verdict which found that Teva owed GSK $235 million in damages for infringing a patent covering a blood pressure drug. 29 March 2018
Americas
A Delaware court has dismissed a patent infringement claim brought by Amgen against a biosimilar maker. 28 March 2018
Big Pharma
GSK has revealed that it will buy Novartis out of their joint consumer healthcare business. 27 March 2018
Americas
A US judge handed a win to Shire late last week, finding that a generic version of its attention deficit hyperactivity disorder drug Adderall XR would infringe Shire’s patents. 27 March 2018
Genetics
There is a complex relationship between the advancing global bioeconomy and the regulatory frameworks covering access to genetic resources, says Diana Jungmann of Di Blasi Parente & Associados. 26 March 2018
Europe
The English High Court has rejected molecular diagnostics company Premaitha Health’s attempt to stop a patent infringement claim. 26 March 2018
Americas
UK-based Indivior has pledged to appeal a US court decision that found a drug developed by generics maker Alvogen doesn’t infringe three of Indivior’s patents. 26 March 2018